EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Approach to Lipid Management in the Patient With Diabetes

Stephanie Kim, Savitha Subramanian iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Stephanie Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Assistant Professor of Clinical Practice Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA 98109, USA. Hauptthemen laut MEDLINE: Dyslipidemias, Diabetes Mellitus, Type 2, Hypolipidemic Agents, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 131 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is associated with increased atherosclerotic cardiovascular disease (ASCVD) risk, a leading cause of morbidity and mortality. Disordered lipid metabolism is a major contributor to ASCVD risk in diabetes. Dyslipidemia in type 2 diabetes is characterized by hypertriglyceridemia, low high-density lipoprotein cholesterol and the presence of small, dense low-density lipoprotein particles. Statins have demonstrated longstanding benefit for reducing ASCVD risk in individuals with diabetes. Newer agents for add-on therapies to statins are now available for additional cardiovascular risk reduction. In this clinical overview, we review the pathogenesis of dyslipidemia in both type 1 and 2 diabetes and provide an update on the management of lipids in the individual with diabetes. We discuss the importance of appropriate risk stratification and individualized treatment selection and the need to avoid therapy inertia to mitigate cardiovascular risk. We also address lipid-related effects of glycemic-lowering therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasDiabetes Mellitus, Type 2Hypolipidemic AgentsDiabetes Mellitus, Type 1HumansHydroxymethylglutaryl-CoA Reductase InhibitorsAtherosclerosisLipidsCardiovascular DiseasesLipid Metabolism

Stichwörter der Autor:innen

GLP-1 receptor agonistsHDL cholesterolLDL cholesterolSGLT2 inhibitorscardiovascular diseasefibratesfish oilhypertriglyceridemiastatinstype 1 diabetestype 2 diabetes

Substanzen

Hypolipidemic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsLipids

Autor:innen und Institutionen

  • Assistant Professor of Clinical Practice Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA 98109, USA.
  • Professor of Medicine Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA 98109, USA.

ORCID-Profile: Savitha Subramanian

Zitieren

APA

Kim, S., & Subramanian, S. (2025). Approach to Lipid Management in the Patient With Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf018

Vancouver

Kim S, Subramanian S. Approach to Lipid Management in the Patient With Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf018

BibTeX
@article{Kim2025,
  author = {Kim, Stephanie and Subramanian, Savitha},
  title = {Approach to Lipid Management in the Patient With Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf018}
}
Kostenlos starten →